SHE · Healthcare

Acrobiosystems Co.Ltd. (301080)

Biotechnology

Acrobiosystems Co.Ltd. (301080) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $10.49B, P/E ratio is 60.67, net margin is 21.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 301080

Market cap
$10.49B
P/E ratio
60.67
Gross profit (TTM)
$682.74M
Net margin
21.8%

Acrobiosystems Co.Ltd. (301080) — FAQ

What is Acrobiosystems Co.Ltd.'s market cap?

Acrobiosystems Co.Ltd. (301080) has a reported market cap of $10.49B (data as of 2026-03-28).

What is 301080's P/E ratio?

The price-to-earnings (P/E) ratio for Acrobiosystems Co.Ltd. (301080) is 60.67 (data as of 2026-03-28).

Does Acrobiosystems Co.Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Acrobiosystems Co.Ltd. (301080). Check the MyAverix Finance app for the latest dividend data.

What sector is Acrobiosystems Co.Ltd. in?

Acrobiosystems Co.Ltd. (301080) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 301080 listed on?

301080 is listed on SHE.

What is Acrobiosystems Co.Ltd.'s net margin?

Acrobiosystems Co.Ltd. (301080) reports a net margin of 21.8% (data as of 2026-03-28).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play